This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2040 Remove Compliance Remove Medicine Related Topics
Compliance Clinical Trials Conditions Epilepsy Chronic Pain Concentrates Data Consumption Treatment Cannabinoids More Related Topics >
article thumbnail

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update

Cannabis Law Report

NOVEMBER 12, 2021

” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose. both recognized leaders in emergency medicine. We recently announced a key milestone with the issuance of a method of use patent for ANEB-001, providing protection through 2040.

Pharmaceutical 52
Pharmaceutical Clinical Trials Business Research and Development 52
article thumbnail

Euro & UK Roundup: Czech Republic, Ireland, San Marino, UK

Cannabis Law Report

SEPTEMBER 28, 2019

As US cannabis investors profit, Greece tries to attract foreign investment in medicinal market. The Greek government has granted a total of 26 cultivation licences for the cultivation and processing of cannabis for medicinal purposes. As US cannabis investors profit, Greece tries to attract foreign investment in medicinal market.

Epilepsy 40
Epilepsy Chronic Pain Medicine Pharmaceutical 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024